• Home >
  • Publications >
  • Development of clinically viable non-muscle myosin II small molecule inhibitors

Development of clinically viable non-muscle myosin II small molecule inhibitors

1 Aug 2025Cell

DOI : 10.1016/j.cell.2025.06.006

Authors

Laszlo Radnai, Erica J. Young, Carlos Kikuti, Katalin Toth, Minghai Zhou, Madalyn Hafenbreidel, Rebecca F. Stremel, Li Lin, Paolo Pasetto, Xiaomin Jin, Aagam Patel, Michael Conlon, Sherri B. Briggs, Leïla Heidsieck, H. Lee Sweeney, James Sellers, Teresa Krieger-Burke, William H. Martin, Jay Sisco, Steven Young, Paul Pearson, Gavin Rumbaugh, Gian Luca Araldi, Steven K. Duddy, Michael D. Cameron, Matthew Surman, Anne Houdusse, Patrick R. Griffin, Theodore M. Kamenecka, Courtney A. Miller